Skip to content

Use of New PET Scan technique for Biliary Tract Cancer

Utility of gallium-68-Fibroblast Activation Protein Inhibitor (FAPi) PET in Biliary Tract Cancers: A Prospective Study - (FAPi) PET

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073350
Enrollment
60
Registered
2024-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C249- Malignant neoplasm of biliary tract, unspecified

Interventions

Intervention1: FAPI PET: Fibroblast activation protein FAPI PET scan Baseline and in cases of suspected biochemical (rising tumor markers) or radiological recurrence. After detailed history taking, an

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and females greater than or equal to 18 years 2.Clinico-radiologically suspected or biopsy proven biliary tract cancers- iHCC and GBC 3.iHCC AJCC stage groups I to IV 4.De-novo locally advanced GBC (suspected T3,T4, N1, vascular involvement) These include AJCC stages III and IV as per the 8th edition. -Incidental GBC including residual GB fossa disease, or hepatoduodenal nodes -Suspected post-treatment recurrence (biochemical or radiological)

Exclusion criteria

Exclusion criteria: 1.Informed consent withdrawal 2.Concurrent malignancy

Design outcomes

Primary

MeasureTime frame
To calculate sensitivity, specificity, positive predictive value and negative predictive value of quantitative and semi-quantitative parameters on FAPi PET.Timepoint: 2 years

Secondary

MeasureTime frame
To evaluate the utility of FAPI PET/CT in - Baseline staging for histopathologically proven locally advanced biliary tract cancer. -Suspected recurrence. Timepoint: 2 years

Countries

India

Contacts

Public ContactDr Shraddha Patkar

Tata Memorial Hospital

drshraddhapatkar@gmail.com9820074818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026